JVM
Financials
Valuation Metrics
JVM's Market Cap is ₩2859B. At end of 2025 it was ₩3125B. Ranked #648 of 2,436 in KR market (top 27%), #263 of 1,649 on KOSDAQ (top 16%), #115 of 365 in Capital Goods (top 32%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 285.93B KRW | KR#648/2,436 Sec#115/365 |
| Revenue | 175.79B KRW | KR#1,087/2,436 Sec#187/365 |
| Net Income | 28.17B KRW | KR#530/2,436 Sec#100/365 |
| Total Assets | 325.91B KRW | KR#972/2,436 Sec#165/365 |
| Net Assets | 233.91B KRW | KR#842/2,436 Sec#144/365 |
| Employees | 317 | KR#753/2,436 Sec#135/365 |
| Value | ||
| P/E | 10.15x | KR#726/2,436 Sec#107/365 |
| P/B | 1.22x | KR#1,658/2,436 Sec#227/365 |
| P/S | 1.63x | KR#1,713/2,436 Sec#243/365 |
| EV/EBITDA | 9.10x | KR#546/2,436 Sec#78/365 |
| FCF Yield | 9.97% | KR#627/2,436 Sec#94/365 |
| Profitability | ||
| ROE | 12.04% | KR#375/2,436 Sec#66/365 |
| ROA | 8.64% | KR#281/2,436 Sec#44/365 |
| Op. Margin | 19.17% | KR#163/2,436 Sec#21/365 |
| Revenue Growth | 6.22% | KR#1,111/2,436 Sec#167/365 |
| Earnings Growth | -2.36% | KR#917/2,436 Sec#147/365 |
| Financial Health | ||
| Debt Ratio | 139.33% | KR#1,021/2,436 Sec#122/365 |
| Total Debt | 31.46B KRW | KR#1,174/2,436 Sec#205/365 |
| FCF | 28.49B KRW | KR#428/2,436 Sec#82/365 |
| Cash | 10.68B KRW | KR#1,640/2,436 Sec#263/365 |
| Current Ratio | 2.53x | KR#743/2,436 Sec#85/365 |
| Net Debt/EBITDA | 0.62x | KR#762/2,436 Sec#103/365 |
| Dividend | ||
| Div. Yield | 2.77% | KR#685/2,436 Sec#87/365 |
| Div. Growth | 30.00% | KR#352/2,436 Sec#72/365 |
| Performance | ||
| 1Y Return | -15.84% | KR#1,129/2,436 Sec#196/365 |
| 1M Return | 9.74% | KR#280/2,436 Sec#31/365 |
| From 52W High | -31.45% | KR#454/2,436 Sec#47/365 |
| 1Y MDD | -40.83% | KR#542/2,436 Sec#61/365 |
| Trading | ||
| Volume | 22,901 shares | KR#1,787/2,436 Sec#294/365 |
| Foreign Own. | 19.73% | KR#231/2,436 Sec#46/365 |
| Per Share | ||
| EPS | 2,330 KRW | KR#354/2,436 Sec#68/365 |
| BPS | 20,275 KRW | KR#506/2,436 Sec#86/365 |
Company Info
JVM, established in 1977 for equipment development, production, and sales, was listed on KOSDAQ in 2006 and became a subsidiary of Hanmi Pharmaceutical Group in 2016. The company researches, develops, produces, and sells hospital and pharmacy automation systems and related software using its proprietary technology, boasting a diverse product lineup. JVM focuses on R&D and production of next-generation products, supplying equipment to 60 countries through global partners to expand its market presence. It is headquartered in Dalseo-gu, Daegu Metropolitan City.